GLP-1RA treatment is associated with gastric residue in an esophagogastroduodenoscopy in patients with diabetes.
No takes yet. Share an insight, caveat, or question.
Kobori et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: